Background: Pharmacodynamic assessment of the systemic effect of inhaled corticosteroids (ICSs) is often done by measuring 24-hour urine free cortisol (UFC) excretion. Knemometry assessing short-term lower-leg growth rate (LLGR) is a more rarely used alternative. Objective: The primary aim of this study was to compare the sensitivity of LLGR and 24-hour UFC excretion for evaluating systemic exposure to ICSs in prepubertal children with asthma. The secondary aim was to evaluate factors influencing the precision of LLGR calculated by the traditional 1 leg nonparametric method versus a new 2 leg parametric method. Methods: The study evaluated 60 children with mild asthma aged 5 to 12 years participating in a randomized controlled trial of ICSs with longitudinal concomitant assessments of LLGR and 24-hour UFC excretion. The sensitivity of the safety assessments was analyzed by comparing LLGR and 24-hour UFC in the placebo run-in period with values in the ICS treatment period by using paired t tests. Factors with a potential influence on LLGR were analyzed by means of ANOVA and the Levene test of homogeneity. Results: The mean LLGR was significantly reduced during the ICS versus placebo run-in periods: 0.18 mm/wk (SD, 0.55 mm/wk) versus 0.45 mm/wk (SD, 0.39 mm/wk), with a mean difference of 0.27 mm/wk (95% CI, 0.05-0.48 mm/wk; P 5 .02). In contrast, there was no difference in 24-hour UFC excretion: 6.91 nmol/ mmol (SD, 4.67 nmol/mmol) versus 7.58 nmol/mmol (SD, 6.17 nmol/mmol), with a mean difference of 0.67 nmol/mmol (95% CI, 21.13 to 2.48 nmol/mmol; P 5.46). We observed no significant difference in parametric determined LLGR caused by the child's age or sex, investigator, or season of measurement, whereas some differences were observed for the nonparametric LLGR.
Regular treatment with inhaled corticosteroids (ICSs) leads to systemic steroid effects.
1,2 Therefore the US Food and Drug Administration (FDA) and the Pediatric Committee of the European Medicines Agency (EMA) require pharmacokinetic and pharmacodynamic evaluation for approving ICS use in children. Guidelines require pharmacodynamic comparisons to be done by means of assessment of 24-hour urine free cortisol (UFC) excretion, which has been shown to be a sensitive measure of the systemic effect of exogenous steroids on the hypothalamicpituitary-adrenocortical (HPA) axis. [3] [4] [5] Knemometry is an alternative method to assess pharmacodynamics from ICSs by measuring short-term lower-leg growth rate (LLGR) in prepubertal children, 6 even in toddlers, 7, 8 and has been suggested as a useful physiologic alternative to measurement of 24-hour UFC excretion. 9 However, there are to our knowledge no previously published studies comparing these 2 assessments of the pharmacodynamics of ICSs in children, and it is unknown which method is the most sensitive.
The primary aim of this study was to compare short-term LLGR and 24-hour UFC excretion for evaluating systemic exposure to ICSs in 60 children aged 5 to 12 years with mild asthma participating in a clinical trial of ICSs. The secondary aim was to evaluate the effect of sex, age, season, and investigator on the precision of LLGR assessments. The latter was done evaluating LLGR calculated by the traditional nonparametric method on 1 leg versus a parametric method, where we increased the number of measurements and included data from both legs.
METHODS Study population, design, and medication
Children 5 to 12 years of age in Tanner stage I with a diagnosis of mild asthma with an FEV 1 of greater than 80% of predicted value were eligible for enrollment in the study. After a screening visit (visit 1), eligible patients entered a 2-week placebo run-in period followed by two 2-week treatment periods of either the fixed or free combination of beclomethasone dipropionate extrafine particle pressurized metered-dose inhaler (pMDI; 50 mg 3 2 twice daily; total daily dose, 200 mg) and formoterol fumarate pMDI (6 mg 3 2 twice daily; total daily dose, 24 mg) delivered through the AeroChamber Plus spacer device (Trudell Medical International, Ontario, Canada). Treatment periods were separated by a 2-week washout period in a crossover design. Clinic visits were performed at the beginning and end of each period, during which The study was conducted in agreement with the guidelines for good clinical practice and was approved by the local ethics committee (clinicaltrials.gov: CCD-1012-PR-0051). Informed consent was obtained from the parents before any study-related procedures were undertaken.
Knemometry

A Valk knemometer (see Fig E1
in this article's Online Repository at www.jacionline.org) was used to measure the child's right and left lower-leg length at each visit, adhering to a predefined protocol. 10, 11 The child was dressed in underwear and placed on the knemometer chair, which was subsequently adjusted to an angle of no more than 908 between the lower and upper legs. We applied talcum on the knees of the child and ensured the arms were kept crossed and held in front of the body to avoid any pressure on the legs. Seat height, depth, and distance to the measuring plates were adjusted by using 3 fixed rulers. The feet of the child were placed on cardboard, on which the position of the child's feet was marked. The knemometer chair settings and the cardboard were reused at all visits to ensure identical positioning of the child.
All knemometry assessments were done by 4 trained investigators (A, B, C, and D), who performed the measurements without reference to previous measurements on that child. At each visit, a total of 16 knemometry measurements were performed. Four measurements of the left and 4 measurements of the right lower leg were performed and noted. The child was asked to stand up and walk a short distance before being reseated, and another 4 measurements of the left and 4 measurements of the right legs were done. 12 The children were instructed not to perform heavy physical exercise on the day of knemometry, and the measurements were performed at the same time of day at every visit (61 hour).
We only included children in the analyses if they had not taken inhaled, nasal, or systemic corticosteroids 2 weeks before the placebo run-in period. In analyses of factors with a possible influence on the precision of LLGR, we only included measurements performed by the same investigator at all visits for each child.
Twenty-four-hour UFC excretion
Families were instructed to collect urine over 24 hours at the end of the placebo run-in period and each treatment period. Initially, the child was instructed to empty the bladder. Thereafter, all urine during the next 24 hours was collected in a plastic collection container, which was kept in a refrigerator in the home. At the clinic, the total volume of urine was noted, and aliquots of 10 mL were stored at 2808C before shipment on cold dry ice to LabCorp Clinical Trials (Hamburg, Germany). At LabCorp, the cortisol and creatinine contents of the samples were analyzed by means of liquid chromatography/tandem mass spectrometry to determine the 24-hour UFC/creatinine excretion ratio.
Statistical analyses
Treatment compliance was defined and calculated as the percentage of days on which the test drug was inhaled based on daily diary recordings.
The lower-leg length at each visit was calculated by a parametric method as the average of the median of the 4 assessments (right and left and right and left, each with 4 repeats, equaling 4 3 4 single measurements). Thereafter, LLGR (in millimeters per week) was calculated as the lower-leg length at the end of the period minus the lower-leg length at the beginning of the period adjusted for period length, which is hereafter termed LLGR 4x4 .
The sensitivity of LLGR was analyzed by comparing LLGR during the placebo run-in period versus that during the ICS treatment periods with paired t tests. The sensitivity of the 24-hour UFC/creatinine excretion ratio (in nanomoles per millimole) was also investigated by comparing results from the placebo run-in and ICS treatment periods with paired t tests.
Thereafter, we analyzed the effect of age (stratified as 5-8 years, >8-11 years, or >11 years), sex, investigator, and season of measurement (spring, summer, autumn, or winter) on LLGR during the placebo run-in period by using 1-and 2-way ANOVA and the Levene test of homogeneity.
Lastly, we performed power analyses for 2-sided paired t tests of LLGR based on the SD of the baseline LLGR during the baseline placebo run-in period to estimate the number of children needed in future trials to obtain an 80% power to detect a range of mean differences in LLGR per week.
The ANOVA and power analyses were also conducted with LLGR calculated by using the conventional nonparametric method, in which lower-leg length is defined as the mean of the 2 first measurements of the left leg before and after the child has been reseated and for which the most deviant measurement is discarded (ie, the mean of the 3 most alike measures, hereafter termed LLGR 2x2 ). 13 A significance level of .05 was used in all analyses. Data processing was conducted with SPSS and SAS software (version 9.4 for Windows; SAS Institute, Cary, NC) and R version 3.2.2 for Windows.
RESULTS
Baseline characteristics
A total of 60 children were included in the trial, but 17 children were excluded from the sensitivity analyses of LLGR and 24-hour UFC excretion (13 because of use of corticosteroids within 2 weeks of the placebo run-in period and 4 because of missing 24-hour urine collection). A further 11 children were excluded from the variance analyses (10 because of different investigators at the visits and 1 child who was the only one measured by investigator D, see the study flowchart in Fig 1) .
The median age of the 43 children (18 [42%] boys) included in the sensitivity analyses was 11.3 years (interquartile range [IQR], 9.6-11.8). The mean FEV 1 at visit 1 was 2.01 L (SD, 0.45 L; Table I ). The median treatment compliance (percentage of days during which the test drug was inhaled) was 98.4% (IQR, 96.3% to 100.0%). The included versus excluded children were older (median, 11.3 years [IQR, 9.6-11.8 years] vs 9.5 years [IQR, 7.6-10.5 years]; P 5 .03) and less often of male sex (18 [42%] vs 12 [71%], P 5 .04) but showed no other differences in baseline characteristics (see Table E1 in this article's Online Repository at www.jacionline.org).
Sensitivity of knemometry and 24-hour UFC excretion (n 5 43)
The mean LLGR 4x4 during the baseline placebo run-in period versus the ICS period was 0.45 mm/wk (SD, 0.39 mm/wk) and 0.18 mm/wk (SD, 0.55 mm/week), respectively. Thus the LLGR 4x4 was significantly reduced during the ICS periods, with a mean difference of 0.27 mm/wk (95% CI, 0.05-0.48 mm/wk; P 5 .02; Fig 2) . In contrast, there was no significant difference in the mean 24-hour UFC excretion during the baseline placebo run-in period versus the ICS period: 7.58 nmol/mmol (SD, 6.17 nmol/mmol) versus 6.91 nmol/mmol (SD, 4.67 nmol/mmol), with a mean difference of 0.67 nmol/mmol (95% CI, 21.13 to 2.48 nmol/mmol; P 5 .46; Fig 3) .
Variance analyses of LLGR
The mean LLGR of the variance analysis study population (n 5 32) during the baseline placebo run-in period was 0.50 mm/wk (SD, 0.33 mm/wk) and 0.55 mm/wk (SD, 0.44 mm/wk) calculated as LLGR 4x4 and LLGR 2x2 , respectively.
Using the parametric LLGR 4x4 , we found no significant difference in 1-way ANOVA because of the child's age (F 5 0.71, P 5 .50), sex (F 5 0.23, P 5 .63), investigator (F 5 0.09, P 5 .92), or season of measurements (F 5 0.63, P 5 .60), and we observed no violation of the assumption of homogeneity of variance (F < 1.21 and P > .30 in all analyses). Furthermore, we found no significant variation in LLGR 4x4 in the 2-way ANOVA interaction analyses (F < 1.25 and P >.30 in all analyses, Table II) .
Using the nonparametric LLGR 2x2 , we observed a trend of variance in 1-way ANOVA induced by the investigator corresponding to an F value of 2.44, which implies that the variance between the investigators is 2.44 times the variance within the investigators (P 5 .10). Furthermore, in the 2-way J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 2 ANOVA, LLGR 2x2 had significant variation because of interaction between the investigator and the season of measurement (F 5 3.56, P 5 .03) and a trend of variation caused by interaction between child's age and sex (F 5 2.87, P 5 .07) and child's age and investigator (F 5 2.86, P 5 .08; Table II ).
Power analyses of knemometric measurements
The results of the power analyses based on the SDs of the LLGR during the baseline placebo run-in period of the population used in ANOVA (SD, 0.33 and 0.44 mm/wk for the parametric LLGR 4x4 and the nonparametric LLGR 2x2 , respectively) are shown in Fig 4, which shows that fewer children are needed to detect the same mean difference in LLGR with our 2 leg parametric LLGR 4x4 method versus the traditional 1 leg nonparametric LLGR 2x2 method of calculating LLGR.
DISCUSSION Primary findings
This study demonstrates a significant decrease in LLGR in children with asthma during treatment with a moderate dose of inhaled beclomethasone dipropionate, whereas there was no change in 24-hour UFC excretion. Thus, knemometry is a more sensitive safety marker for systemic effects of ICSs than 24-hour UFC excretion, and sensitivity can be further increased by using a 2 leg parametric method to determine LLGR. These findings should be considered by legislative authorities in the future.
Strengths and limitations of the study
This first direct comparative analysis of LLGR and 24-hour UFC excretion for evaluating systemic effects of ICSs in children with asthma represents the hitherto largest knemometry data set published. Another advantage is the single-center setup, which is recommended by the FDA to limit interobserver variation in the knemometry procedure.
14 Furthermore, intraobserver variation was reduced because all knemometric assessments were done by trained investigators, who performed the measurements without any reference to previous measurements on that child.
In most knemometry studies, LLGR is calculated by a nonparametric method based only on left leg length, which is defined as the mean of the first 2 of 4 measurements before and after the child had been reseated (LLGR 2x2 ) with or without discarding the most deviant measurement. 15 In our study we measured both the left and right legs twice and used all 16 measurements in a parametric approach to calculate LLGR (LLGR 4x4 ), which resulted in a lower SD compared with the nonparametric 1 leg LLGR 2x2 and reduced the effect of interobserver and intraobserver variability. In accordance, the variance analyses showed no significant effect of investigator, season, sex, or age on the knemometry results for the parametric LLGR 4x4 , whereas we observed some influence of these factors on the nonparametric LLGR 2x2 .
An additional strength is that the study group solely compries children with mild asthma, which minimized any possible influence on growth from poorly controlled asthma. Furthermore, the children were instructed not to perform heavy physical exercise on the day of knemometry, and the measurements were performed at the same time of day at every visit (61 hour) to diminish diurnal variation in water content of the tissue between visits.
11,12 Short-term studies of growth might be confounded by variations in normal growth patterns induced by The parametric LLGR 4x4 is defined as lower-leg length calculated as the mean of the median measurements of 4 assessments on each leg performed before and after the child had been reseated (using 4 3 4 measurements). àThe nonparametric LLGR 2x2 is defined as lower-leg length calculated as the mean of the 2 first measurements of the left leg before and after the child has been reseated, where the most deviant measurement was discarded (using 2 3 2 measurements). season, age-related growth ''spurts,'' or sex differences, but we observed no significant variance in LLGR 4x4 by these factors partly due to the short observation periods.
This study was conducted with data from a phase III study for Chiesi Farmaceutici S.p.A (Parma, Italy). However, the funding agency had no role in the design and conduct of the current study, and Chiesi did not contribute to preparation, review, or approval of the manuscript.
Interpretation and clinical implications
It is well documented that treatment of children with asthma with ICSs may lead to unwanted systemic side effects, such as suppressed HPA axis and affected childhood growth velocity. 1, 2 Therefore quantification of such effects is important for drug legislative authorities. The degree of HPA axis and cortisol suppression is related to the dose and type of administered corticosteroid, as well as the delivery device for ICSs. 16, 17 Based on this, the FDA and EMA recommend assessment of 24-hour UFC excretion because this is a sensitive measure of endogenous cortisol production. 18, 19 However, LLGR measured by using knemometry is an alternative safety tool to define the lowest dose of ICS at which systemic activity can be detected, to detect dose-related effects, to compare the effects of specific drugs and inhaler devices, and to evaluate dose administration regimens.
In this study we found a significant decrease in LLGR during treatment with a moderate dose of ICS, whereas we observed no change in 24-hour UFC excretion, suggesting that knemometry is superior to 24-hour UFC to assess systemic activity of ICSs in children with asthma. These findings align with those of a number of previous studies, 15, 20, 21 whereas one smaller study of 14 boys and 10 girls with asthma aged 7 to 12 years showed suppression of both LLGR and 24-hour UFC from a moderate to a high dose of beclomethasone dipropionate (total daily dose, 200-400 mg) delivered through pMDIs with HFA and chlorofluorocarbon propellants. 22 To date, 12-and 24-hour UFC excretion are still the most commonly used safety markers for evaluating the systemic effects of ICSs, although they require careful collection and storage of urine, and the fact that LLGR is more sensitive for detecting systemic activity of ICSs. In addition, our study shows that knemometry sensitivity can be further improved by utilizing a leg parametric approach to determine LLGR.
Furthermore, no studies have previously demonstrated an adverse effect on markers of bone and collagen metabolism from normal ICS doses, suggesting LLGR is more sensitive than changes in markers of bone metabolism for detecting systemic effects and differences in systemic effects between exogenous steroids.
The knemometry methodology is feasible, noninvasive, and accurate in young children 15 and enables detection of changes in lower-leg length over 1 to 2 weeks with the potential to investigate the influence of ICSs in short-term studies. 6 However, the method is subjected to potential sources of errors conditional to the child and investigator. 11 Thus studies of short-term growth in children treated with exogenous glucocorticoids have shown a technical error of knemometry on lower-leg length in the range of 0.07 to 0.13 mm 23, 24 and a large span in LLGR of 0.28 to 0.69 mm/wk (SD, 0.06-0.70 m/wk) during placebo periods [24] [25] [26] [27] [28] when the length is calculated by using the conventional 1 leg nonparametric method (LLGR 2x2 ). Previous studies have not shown any improvement in sensitivity from using more than 4 measurements or from discarding the most deviant value, 13, 15 which is in contrast to our study showing, as expected, a lower SD when using all 16 measurements to determine LLGR by a 2 leg parametric approach (LLGR 4x4 ). Interobserver variation between 2 experienced observers has been estimated as 0.08% in a series of double measurements in a population of healthy children. 29 This underscores the importance of using trained personnel and is in line with our study showing no significant investigator variance in the LLGR 4x4 assessments.
Knemometry has several advances for assessing ICS side effects compared with long-and intermediate-term growth studies. First, the measurement error on the axiological measurement is much smaller than that for stature height. 12, 30 Second, the observation periods can be very short (weeks). Third, crossover trials can be performed without taking the nonlinearity of growth into account. Fourth, randomized, controlled, double-blind conditions can be applied. 31 Importantly, although knemometry is a very sensitive instrument to detect systemic activity of ICSs at the lowest possible dose, LLGR cannot be extrapolated to linear growth. 31 A significant reduction in LLGR in a short-term knemometry study cannot be used to predict a long-term ICS-mediated decrease in growth velocity or adult height. 32, 33 Short-term knemometry should be given preference over 24-hour UFC excretion by legislative authorities to evaluate the systemic activity of ICSs in children with asthma because LLGR is at least as sensitive as 24-hour UFC for such safety assessment. For that purpose, this study provides a graph to capture the number of children required to detect a clinically relevant suppression of LLGR with 80% power, which can be reduced by calculating LLGR by a parametric 2 leg approach from 16 measurements performed by trained investigators.
In conclusion, we demonstrate that knemometry is a superior measurement of systemic activity from ICSs compared with 24-hour UFC excretion. Therefore knemometry should be preferred for pharmacodynamic studies of ICSs in the management of children with asthma.
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Clinical implications: Knemometry is more sensitive than 24-hour UFC excretion for investigating the systemic effects of ICSs in children with asthma, which should be considered by legislative authorities in the future.
